ANDOVER, Mass.--(BUSINESS WIRE)--DeuteRx, LLC, is a research and development-focused biotechnology company dedicated to improving racemic small molecule marketed drugs and drug candidates intended for ...
The latest short science news items from C&EN. In order for the catalyst to be stereoselective, its ligand has to be able to distinguish between the different alkyl substituents. Fu’s hunch about how ...
Acute bronchiolitis in infants frequently results in hospitalization, but there is no established consensus on inhalation therapy — either the type of medication or the frequency of administration — ...
From 2001 to 2011, the US Food and Drug Administration approved 9 single-enantiomer drugs with racemic precursors. None showed pre-approval evidence of improved efficacy over the racemic precursor. We ...
When chemists need to separate one chiral molecule from a mixture of enantiomers—for instance, when synthesizing potential drug molecules—they often turn to high-performance liquid chromatography ...
THE separation of racemic mixtures of optical isomers is still limited, with rare exceptions, to the methods of Pasteur. For this reason the resolution of substances which seem identical in the ...
New biocatalytic and chemocatalytic routes to chiral intermediates and developments in simulated-moving-bed and supercritical-fluid chromatography for resolving racemic mixtures. The prevalence of ...
On April 16, 2018 in a precedential opinion, the United States Court of Appeals for the Federal Circuit, Sumitomo Dainippon Pharma v. Emcure Pharms., Nos. 2017-1798, -1799, -1800, affirmed the United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results